SCHEMBL10951502

SCHEMBL10951502

CSC(C=O)c1ccncc1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 2/20 0.33
CYP19A1 P11511 1/20 0.33
GAA P10253 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
DDAH1 O94760 1/20 0.31
NOS1 P29475 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28201035 0.78 CYP2D6 (0.39) L3MBTL1MEN1KMT2A
SCHEMBL15564590 0.77 CFTR (0.44) CYP3A4CYP2C19SLC6A2SLC6A4SLC6A3
SCHEMBL3119634 0.75 ADRB2 (0.40) CYP2C19SLC6A4SLC6A3CYP19A1HSD17B10
SCHEMBL1338441 0.71 CYP3A4 (0.43) CYP3A4CYP2C19SLC6A2SLC6A4SLC6A3
SCHEMBL22383612 0.71 CYP3A4 (0.39) CYP3A4CYP2C19SLC6A2SLC6A4SLC6A3
SCHEMBL242307 0.70 SLC6A2 (0.42) CYP3A4CYP2C19SLC6A2SLC6A4SLC6A3
SCHEMBL9129258 0.69 CYP3A4 (0.44) CYP3A4CYP2C19SLC6A2SLC6A4SLC6A3
SCHEMBL23539762 0.67 SLC6A2 (0.39) CYP3A4CYP2C19SLC6A2SLC6A4SLC6A3
SCHEMBL4758242 0.67 SLC6A2 (0.39) CYP3A4CYP2C19SLC6A2SLC6A4SLC6A3
SCHEMBL3106209 0.67 SLC6A2 (0.39) CYP3A4CYP2C19SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4500535-A ANTIARTHRITIC AGENTS PFIZER INC. (US) 1985-02-19 US disclosed
US-4371696-A ANTIINFLAMMATORY AND IMMUNOREGULATORY AGENTS PFIZER INC. (US) 1983-02-01 US disclosed